Stifel Maintains Buy on Inspire Medical Systems, Lowers Price Target to $65

Benzinga Newsdesk www.benzinga.com Negative 65.1%

Neg 65.1% Neu 0% Pos 0%

Stifel analyst Jonathan Block maintains Inspire Medical Systems (NYSE:INSP) with a Buy and lowers the price target from $70 to $65.